secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2021-09-17T23:59:59+00:00
Accession:  0001640334-21-002236
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences receives Nasdaq delisting notice for bid price non-compliance; changes fiscal year end
--------------------------------------------------------------------------------

- Received Nasdaq notice on Sept 13, 2021 for failure to meet $1.00 minimum bid price (Listing Rule 5550(a)(2)).
- Has 180 days until March 14, 2022 to regain compliance by closing bid price >= $1.00 for 10 consecutive business days.
- Possible second 180-day cure period if other standards met; otherwise delisting with appeal rights.
- Board resolved on Sept 17, 2021 to change fiscal year end from Aug 31 to Dec 31, effective Jan 1, 2022.
- No immediate effect on listing; company will monitor price and consider options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033421002236/0001640334-21-002236-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033421002236/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-21-002236

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer